Page 17 - Read Online

Santoni et al. J Cancer Metastasis Treat 2020;6:22 I http://dx.doi.org/10.20517/2394-4722.2020.49 Page 13 of 14

their chemoresistance to temozolomide. Biol Open 2016;5:669-77.
41. Shen X, Li J, Liao W, Wang J, Chen H, et al. microRNA-149 targets caspase-2 in glioma progression. Oncotarget 2016;7:26388-99.
42. Yin D, Ogawa S, Kawamata N, Leiter A, Ham M, et al. miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma
multiforme. Oncogene 2013;32:1155-63.
43. Godlewski J, Nowicki MO, Bronisz A, Williams S, Otsuki A, et al. Targeting of the Bmi-1 oncogene/stem cell renewal factor by
microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res 2008;68:9125-30.
44. Feng R, Dong L. Inhibitory effect of miR-184 on the potential of proliferation and invasion in human glioma and breast cancer cells in
vitro. Int J Clin ExpPathol 2015;8:9376-82.
45. Glasgow SM, Laug D, Brawley VS, Zhang Z, Corder A, et al. The miR-223/nuclear factor I-A axis regulates glial precursor proliferation
and tumorigenesis in the CNS. J Neurosci 2013;33:13560-8.
46. Xiao B, Tan L, He B, Liu Z, Xu R. MiRNA-329 targeting E2F1 inhibits cell proliferation in glioma cells. J Transl Med 2013;11:172.
47. Guo M, Jiang Z, Zhang X, Lu D, Ha AD, et al. miR-656 inhibits glioma tumorigenesis through repression of BMPR1A. Carcinogenesis
2014;35:1698-706.
48. Fang B, Zhu J, Wang Y, Geng F, Li G. MiR-454 inhibited cell proliferation of human glioblastoma cells by suppressing PDK1 expression.
Biomed Pharmacother 2015;75:148-52.
49. Chen Y, Hu X, Li Y, Zhang H, Fu R, et al. Ars2 promotes cell proliferation and tumorigenicity in glioblastoma through regulating miR-
6798-3p. Sci Rep 2018;8:15602.
50. Koshkin PA, Chistiakov DA, Nikitin AG, Konovalov AN, Potapov AA, et al. Analysis of expression of micrornas and genes involved
in the control of key signaling mechanisms that support or inhibit development of brain tumors of different grades. Clin Chim Acta
2014;430:55-62.
51. Yang W, Yu H, Shen Y, Liu Y, Yang Z, et al. MiR-146b-5p overexpression attenuates stemness and radioresistance of glioma stem cells by
targeting HuR/lincRNA-p21/B catenin pathway. Oncotarget 2016;7:41505-26.
52. Bhan A, Soleimani M, Mandai SS. Long non coding RNA and cancer: a new paradigm. Cancer Res 2017;77:3965-81.
53. Wang L, Zhengwen H. Functional roles of long non-coding RNAs (LncRNAs) in glioma stem cells. Med SciMonit 2019;25:7567-73.
54. Chi HC, Tsai CY, Tsai MM, Yeh CT, Lin KH. Roles of long noncoding RNAs in recurrence and metastasis of radiotherapy-resistant
cancer stem cells. Int J Mol Sci 2017;18:1903.
55. Engreitz JM, Ollikainen N, Guttman M. Long non-coding RNAs: Spatial amplifiers that control nuclear structure and gene expression.
Nat Rev Mol Cell Biol 2016;17:756-70.
56. Tannous BA,Teng J. Secreted blood reporters: insights and applications. BiotechnolAdv 2011;29:997-1003.
57. Kang CM, Bai HL, Li XH, Huang RY, Zhao JJ, et al. The binding of lncRNA RP11-732M18.3 with 14-3-3 β/α accelerates p21
degradation and promotes glioma growth. EBioMedicine 2019;45:58-69.
58. Lin TK, Chang CN, Tsai CS, Huang YC, Lu YJ, et al. The long non-coding RNA LOC441204 enhances cell growth in human glioma. Sci
Rep 2017;7:5603.
59. Zhou XY, Liu H, Ding ZB, Xi HP, Wang GW. lncRNA SNHG16 exerts oncogenic functions in promoting proliferation of glioma through
suppressing p21. Pathol Oncol Res 2020;26:1021-8.
60. Fei F, He Y, He S, He Z, Wang Y, et al. LncRNA SNHG3 enhances the malignant progress of glioma through silencing KLF2 and p21.
Biosci Rep 2018;38:BSR20180420.
61. Cai G, Zhu Q, Yuan L, Lan Q. LncRNA SNHG6 acts as a prognostic factor to regulate cell proliferation in glioma through targeting p21.
Biomed Pharmacother 2018;102:452-7.
62. Hu S, Xu L, Li L, Luo D, Zhao H, et al. Overexpression of lncRNA PTENP1 suppresses glioma cell proliferation and metastasis in vitro.
Onco Targets Ther 2018;12:147-56.
63. Huarte M, Guttman M, Feldser D, Garber M, Koziol MJ, et al. A large intergenic noncoding RNA induced by p53 mediates global gene
repression in the p53 response. Cell 2010;142:409-19.
64. Hall JR, Messenger ZJ, Tam HW, Phillips SL, Recio L, et al. Long noncoding RNA lincRNA-p21 is the major mediator of UVB-induced
and p53-dependent apoptosis in keratinocytes. Cell Death Dis 2015;6:e1700
65. Dimitrova N, Zamudio JR, Jong RM, Soukup D, Resnick R, et al. LincRNA-p21 activates p21 in cis to promote Polycomb target gene
expression and to enforce the G1/S checkpoint. Mol Cell 2014;54:777-90.
66. Deng J, Yang M, Jiang R, An N, Wang X, et al. Long non-coding RNA HOTAIR regulates the proliferation, self-renewal capacity,
tumor formation and migration of the cancer stem- like cell (CSC) subpopulation enriched from breast cancer cells. PLoS One
2017;12:e0170860.
67. Dutertre M, Lambert S, Carreira A, Amor-Guéret M, Vagner S. DNA damage: RNA-binding proteins protect from near and far. Trends
BiochemSci 2014;39:141-9.
68. Wang G, Li Z, Zhao Q, Zhu Y, Zhao C, et al. LincRNA-p21 enhances the sensitivity of radiotherapy for human colorectal cancer by
targeting the Wnt/β-catenin signaling pathway. Oncol Rep 2014;31:1839-45.
69. Shen Y, Liu Y, Sun T, Yang W. LincRNA-p21 knockdown enhances radiosensitivity of hypoxic tumor cells by reducing autophagy
through HIF-1/Akt/mTOR/P70S6K pathway. Exp Cell Res 2017;358:188-98.
70. Bi YY, Shen G, Quan Y, Jiang W, Xu F. Long noncoding RNA FAM83H-AS1 exerts an oncogenic role in glioma through epigenetically
silencing CDKN1A (p21). J Cell Physiol 2018;233:8896-907.
71. Li XS, Shen FZ, Huang LY, Hui L, Liu RH, et al. lncRNA small nucleolar RNA host gene 20 predicts poor prognosis in glioma and
promotes cell proliferation by silencing P21. Onco Targets Ther 2019;12:805-14.